Roopa Industries

Why is Roopa Industries Ltd falling/rising?

As of 10-Aug, Roopa Industries Ltd's stock price is declining, currently at Rs 47.31, down 6.85% and underperforming its sector. The stock is trading below all key moving averages, indicating a bearish trend and decreased investor confidence.

As of 10-Aug, Roopa Industries Ltd's stock price is falling, currently at Rs 47.31, reflecting a decrease of Rs 3.48 or 6.85%. The stock has underperformed its sector by 6.81% today and reached an intraday low of Rs 46.2, which is a decline of 9.04%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Investor participation has also decreased significantly, with delivery volume dropping by 95.83% compared to the 5-day average. This lack of investor interest suggests a decline in confidence in the stock. Over the past week, the stock has fallen by 5.34%, while the benchmark Sensex has only decreased by 0.12%. Although the stock has shown some positive performance over the longer term, such as a 7.43% increase year-to-date, the recent trends indicate a clear downward movement in the stock price.

Which are the latest news on Roopa Industries?

Should I buy, sell or hold Roopa Industries Ltd?

How big is Roopa Industries?

As of 10th June, Roopa Industries Ltd has a market capitalization of 39.00 Cr, with recent net sales of 127.49 Cr and a net profit of 0.08 Cr. Shareholder's funds are 17.49 Cr, and total assets amount to 76.46 Cr as of March 2025.

As of 10th June, Roopa Industries Ltd has a market capitalization of 39.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, Roopa Industries reported Net Sales of 127.49 Cr and a Net Profit of 0.08 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 17.49 Cr and Total Assets of 76.46 Cr.

Who are in the management team of Roopa Industries?

The management team of Roopa Industries includes T G Raghavendra (Chairman & Managing Director), V J Sarma (Whole-time Director), and three Non-Executive & Independent Directors: O Mohan Rao, A Satyanarayana Murthy, and Karunasree.

The management team of Roopa Industries includes the following individuals:<BR><BR>1. T G Raghavendra - Chairman & Managing Director<BR>2. V J Sarma - Whole-time Director<BR>3. O Mohan Rao - Non-Executive & Independent Director<BR>4. A Satyanarayana Murthy - Non-Executive & Independent Director<BR>5. Karunasree - Non-Executive & Independent Director<BR><BR>If you need more details about their roles or the company, feel free to ask!

Who are the peers of the Roopa Industries?

Roopa Industries' peers include Mangalam Drugs, Sandu Pharma, Murae Organisor, Lasa Supergeneri, ANG Lifesciences, Medi Caps, Chandra Bhagat, Welcure Drugs, and Guj. Terce Labs. ANG Lifesciences has the highest 1-year return at -7.18%, while Mangalam Drugs has the lowest at -65.43%, with Roopa Industries at -23.66%.

Peers: The peers of Roopa Industries are Mangalam Drugs, Sandu Pharma., Murae Organisor, Lasa Supergeneri, ANG Lifesciences, Medi Caps, Chandra Bhagat, Welcure Drugs, and Guj. Terce Labs.<BR><BR>Quality Snapshot: Excellent growth is observed at Roopa Industries, while Below Average management risk is found at Mangalam Drugs, Sandu Pharma., Murae Organisor, Lasa Supergeneri, ANG Lifesciences, Medi Caps, Chandra Bhagat, Guj. Terce Labs., and the rest. Average capital structure is noted at Sandu Pharma. and Welcure Drugs, while Good capital structure is seen at Sandu Pharma. and Medi Caps, with the rest having Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is ANG Lifesciences at -7.18%, while the peer with the lowest 1-year return is Mangalam Drugs at -65.43%. Roopa Industries has a 1-year return of -23.66%, which is better than Mangalam Drugs but worse than ANG Lifesciences. Additionally, several peers, including Murae Organisor, Lasa Supergeneri, Welcure Drugs, and Guj. Terce Labs., have negative six-month returns.

What does Roopa Industries do?

Roopa Industries Ltd manufactures bulk drugs and drug intermediates in the Pharmaceuticals & Biotechnology sector. As of March 2026, it reported net sales of 30 Cr and a net profit of -1 Cr, with a market cap of INR 39 Cr.

Overview: <BR>Roopa Industries Ltd is engaged in the manufacturing of bulk drugs and drug intermediates within the Pharmaceuticals & Biotechnology industry, categorized as a Micro Cap company.<BR><BR>History: <BR>Roopa Industries Limited was incorporated in 1985 as "Roopa Granites Private Limited," changed to "Roopa Granites Limited" in 1992, and further renamed to M/s. Roopa Industries in 1994. The latest quarterly results report net sales and profit for March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 30 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -1 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 39 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 9.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.68 <BR>Return on Equity: 23.69% <BR>Price to Book: 2.19 <BR><BR>Contact Details: <BR>Address: 17/745 Alur Road, Kurnool District ADONI Andhra Pradesh : 518301 <BR>Fax: 91-40-23310379 <BR>Email: info@roopaindustries.com <BR>Website: http://www.roopaindustries.com

Are Roopa Industries Ltd latest results good or bad?

Roopa Industries Ltd's latest results show improved operational efficiency with a highest operating margin of 10.19%, but the company reported a net loss of ₹1.43 crores, contrasting with a profit in the previous quarter, raising concerns about its growth sustainability. While there are operational gains, the decline in revenue and net loss indicate challenges ahead for investors.

Roopa Industries Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company achieved its highest operating margin in eight quarters at 10.19%, indicating improved operational efficiency. However, this positive operational performance was overshadowed by a significant net loss of ₹1.43 crores, a stark contrast to the profit of ₹0.77 crores reported in the previous quarter (Q3 FY26).<BR><BR>Revenue for the quarter was ₹30.14 crores, which reflects a 10.14% decline compared to the previous quarter but shows a slight year-on-year increase of 1.04%. The negative net profit and declining revenue raise concerns about the sustainability of the company's growth, especially given the high leverage ratios and working capital pressures it faces.<BR><BR>Overall, while Roopa Industries has demonstrated operational improvements, the recent loss at the net profit level suggests challenges that investors should carefully consider. The company's ability to maintain these operational gains while returning to profitability will be crucial moving forward.

When is the next results date for Roopa Industries Ltd?

The next results date for Roopa Industries Ltd is 30 May 2026.

The next results date for Roopa Industries Ltd is scheduled for 30 May 2026.

How has been the historical performance of Roopa Industries?

Roopa Industries has shown significant growth in net sales, increasing from 26.58 Cr in Mar'21 to 120.69 Cr in Mar'25, with profits also rising, despite a sharp increase in raw material costs. Operating profit reached 6.41 Cr in Mar'25, and profit after tax rose to 2.03 Cr, while total assets and liabilities grew to 76.46 Cr each.

Answer:<BR>The historical performance of Roopa Industries shows significant growth in net sales and profit over the years.<BR><BR>Breakdown:<BR>Roopa Industries has demonstrated a strong upward trend in net sales, increasing from 26.58 Cr in Mar'21 to 120.69 Cr in Mar'25, with a notable jump from 70.43 Cr in Mar'24. The total operating income followed a similar trajectory, reaching 120.69 Cr in Mar'25, up from 70.43 Cr in the previous year. However, raw material costs surged to 114.42 Cr in Mar'25, reflecting a substantial increase from 47.06 Cr in Mar'24. Despite this, the operating profit (PBDIT) rose to 6.41 Cr in Mar'25, compared to 5.68 Cr in Mar'24, indicating improved operational efficiency. Profit before tax also increased to 2.72 Cr in Mar'25 from 2.17 Cr in Mar'24, leading to a profit after tax of 2.03 Cr in Mar'25, up from 1.52 Cr in the prior year. The company's total assets grew to 76.46 Cr in Mar'25, while total liabilities also increased to 76.46 Cr, reflecting a balanced growth. The cash flow from operating activities showed a decline to -6.00 Cr in Mar'25, contrasting with a positive cash flow of 2.00 Cr in Mar'24, but the overall cash position improved with closing cash and cash equivalents rising to 3.00 Cr in Mar'25 from 2.00 Cr in Mar'24.

Is Roopa Industries overvalued or undervalued?

As of November 10, 2025, Roopa Industries is considered undervalued with a favorable PE Ratio of 18.65 and strong growth potential, making it a compelling investment opportunity compared to its peers, despite recent stock performance lagging behind the Sensex.

As of 10 November 2025, Roopa Industries has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued. Key ratios include a PE Ratio of 18.65, an EV to EBITDA of 14.98, and a PEG Ratio of 0.75, indicating strong potential for growth relative to its price.<BR><BR>In comparison to peers, Roopa Industries shows a more favorable valuation than Sun Pharma, which has a PE Ratio of 35.15 and is deemed expensive, as well as Divi's Lab, which is classified as very expensive with a PE Ratio of 71.55. Despite recent stock performance lagging behind the Sensex, particularly with a year-to-date return of -33.75% compared to the Sensex's 6.91%, the overall valuation metrics suggest that Roopa Industries presents a compelling investment opportunity.

Who are the top shareholders of the Roopa Industries?

The top shareholders of Roopa Industries are Star Niochem Pvt Limited with 18.91%, followed by public shareholder Sangeetha S at 9.51%. Individual investors own 40.95%, and there is one foreign institutional investor with a 0.25% stake, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Roopa Industries include Star Niochem Pvt Limited, which holds the largest stake at 18.91%. Following that, the highest public shareholder is Sangeetha S, with a holding of 9.51%. Additionally, individual investors collectively own 40.95% of the company. There is also one foreign institutional investor (FII) with a 0.25% stake. Notably, there are no pledged promoter holdings or mutual funds involved in this company.

What is the technical trend for Roopa Industries?

As of June 4, 2025, Roopa Industries shows a neutral trend with a slight bullish bias, indicated by mixed signals from the MACD and daily moving averages, while weekly indicators suggest upward momentum.

As of 4 June 2025, the technical trend for Roopa Industries has changed from mildly bearish to sideways. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The Bollinger Bands are mildly bullish on both the weekly and monthly time frames, suggesting some upward momentum. However, the daily moving averages are mildly bearish, which adds a cautionary note. The KST and Dow Theory are both mildly bullish on the weekly and monthly charts, reinforcing some positive sentiment. Overall, the current stance is neutral with a slight bullish bias, driven primarily by the weekly indicators.

Has Roopa Industries declared dividend?

No Dividend History Available